-
1.发明申请USE OF BREAST CANCER ASSOCIATED MEMBRANE PROTEINS (BCMP) FOR TREATMENT, PROPHYLAXIS AND DIAGNOSIS OF BREAST CANCER 审中-公开使用乳腺癌相关膜蛋白（BCMP）进行治疗，预防和诊断乳腺癌
公开(公告)号：WO0162784A3
公开(公告)日：2002-01-31
申请号：PCT/GB0100748
申请日：2001-02-21
Applicant: OXFORD GLYCOSCIENCES UK LTD , BOYD ROBERT SIMON , STAMPS ALASDAIR CRAIG , TERRETT JONATHAN ALEXANDER
Inventor： BOYD ROBERT SIMON , STAMPS ALASDAIR CRAIG , TERRETT JONATHAN ALEXANDER
IPC: G01N33/50 , A61K31/7088 , A61K31/7105 , A61K38/00 , A61K39/00 , A61K39/395 , A61K47/42 , A61K48/00 , A61K49/00 , A61K51/10 , A61P35/00 , C07K14/47 , C07K16/32 , C12M1/00 , C12N1/21 , C12N15/09 , C12N15/12 , C12Q1/68 , G01N33/15 , G01N33/566 , G01N33/574 , G01N33/577 , A61K38/17 , C07K16/18 , G01N33/53
CPC classification number: C07K14/47 , A61K9/0019 , A61K39/00 , A61K47/42 , A61K48/00 , A61K49/0002 , A61K51/1051 , A61K2039/505 , A61K2039/53 , C07K2319/00 , G01N33/57407 , G01N33/57415 , G01N33/57419 , G01N33/57434 , G01N33/57438 , G01N2500/00 , G01N2800/52
Abstract: The present invention provides methods and compositions for screening, diagnosis and prognosis of breast cancer, for monitoring the effectiveness of breast cancer treatment, and for drug development.
Abstract translation: 本发明提供乳腺癌筛查，诊断和预后的方法和组合物，用于监测乳腺癌治疗的有效性和用于药物开发。
-
公开(公告)号：WO2003087831A2
公开(公告)日：2003-10-23
申请号：PCT/GB2003/001559
申请日：2003-04-10
Applicant: OXFORD GLYCOSCIENCES (UK) LTD , HUDSON, Lyndsey, J , STAMPS, Alasdair, Craig , TERRETT, Jonathan, Alexander
IPC: G01N33/574
CPC classification number: G01N33/57415 , G01N2500/00 , G01N2800/52
Abstract: The present invention provides methods and compositions for the screening, diagnosis and therapy of breast cancer, for monitoring the effectiveness of breast cancer treatment, and for drug development.
Abstract translation: 本发明提供了用于乳腺癌筛查，诊断和治疗的方法和组合物，用于监测乳腺癌治疗的有效性和用于药物开发。
-
3.发明申请
公开(公告)号：WO0146392A3
公开(公告)日：2001-12-06
申请号：PCT/GB0004963
申请日：2000-12-21
Applicant: OXFORD GLYCOSCIENCES UK LTD , MCKENZIE EDWARD ALEXANDER , STAMPS ALASDAIR CRAIG , TERRETT JONATHAN ALEXANDER , TYSON KERRY LOUISE
Inventor： MCKENZIE EDWARD ALEXANDER , STAMPS ALASDAIR CRAIG , TERRETT JONATHAN ALEXANDER , TYSON KERRY LOUISE
IPC: C12N15/09 , A61K31/7088 , A61K38/00 , A61K39/395 , A61K45/00 , A61K48/00 , A61P3/10 , A61P7/02 , A61P9/08 , A61P11/06 , A61P17/02 , A61P17/16 , A61P19/02 , A61P25/00 , A61P25/28 , A61P27/00 , A61P29/00 , A61P31/00 , A61P35/00 , A61P37/06 , A61P43/00 , C07K16/40 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10 , C12N9/24 , C12N15/56 , A61K38/47
CPC classification number: C12Y302/01166 , C12N9/2402
Abstract: The present invention provides a homologue to heparanase which is present in three splice variants.
Abstract translation: 本发明提供了存在于三个剪接变体中的乙酰肝素酶的同源物。
-
公开(公告)号：WO2006123122A3
公开(公告)日：2006-11-23
申请号：PCT/GB2006/001781
申请日：2006-05-16
Applicant: UCB S.A. , STAMPS, Alasdair Craig
Inventor： STAMPS, Alasdair Craig
IPC: A61K39/395 , A61K38/17 , A61P35/00
Abstract: The present invention relates to new uses of PSK-I in the diagnosis, screening, treatment and prophylaxis of ovarian and lung cancer. The invention also provides compositions comprising PSK-I, including vaccines, antibodies that are immunospecific for PSK-I and agents which interact with or modulate the expression or activity of PSK-I or which modulate the expression of the nucleic acid which codes for PSK-I .
-
Patent Agency Ranking
公开(公告)号：WO2006123122A2
公开(公告)日：2006-11-23
申请号：PCT/GB2006001781
申请日：2006-05-16
Applicant: UCB SA , STAMPS ALASDAIR CRAIG
Inventor： STAMPS ALASDAIR CRAIG
IPC: A61K39/395 , A61K38/17 , A61P35/00 , G01N33/574
CPC classification number: G01N33/57484 , A61K38/1709 , A61K39/395 , G01N2500/00 , G01N2800/52
Abstract: The present invention relates to new uses of PSK-I in the diagnosis, screening, treatment and prophylaxis of ovarian and lung cancer. The invention also provides compositions comprising PSK-I, including vaccines, antibodies that are immunospecific for PSK-I and agents which interact with or modulate the expression or activity of PSK-I or which modulate the expression of the nucleic acid which codes for PSK-I .
Abstract translation: 本发明涉及PSK-1在诊断，筛选，治疗和预防卵巢癌和肺癌中的新用途。 本发明还提供包含PSK-1的组合物，包括疫苗，对PSK-1具有免疫特异性的抗体和与PSK-1的表达或活性相互作用或调节PSK-1的表达或活性或调节编码PSK- 一世 。
-
公开(公告)号：WO2005105143A2
公开(公告)日：2005-11-10
申请号：PCT/GB2005/001698
申请日：2005-05-04
Applicant: CELLTECH R & D LIMITED , STAMPS, Alasdair, Craig
Inventor： STAMPS, Alasdair, Craig
IPC: A61K39/395
CPC classification number: A61K39/0011
Abstract: The present invention relates to new uses of LTK in the diagnosis, screening, treatment and prophylaxis of ovarian and lung cancer. The invention also provides compositions comprising LTK, including vaccines, antibodies that are immunospecific for LTK and agents which interact with or modulate the expression or activity of LTK or which modulate the expression of the nucleic acid which codes for LTK.
Abstract translation: 本发明涉及LTK在诊断，筛选，治疗和预防卵巢癌和肺癌中的新用途。 本发明还提供包含LTK的组合物，包括疫苗，对LTK具有免疫特异性的抗体和与LTK的表达或活性相互作用或调节LTK的表达或活性或调节编码LTK的核酸表达的试剂。
-
公开(公告)号：WO2005105143A3
公开(公告)日：2006-04-27
申请号：PCT/GB2005001698
申请日：2005-05-04
Applicant: CELLTECH R&D LTD , STAMPS ALASDAIR CRAIG
Inventor： STAMPS ALASDAIR CRAIG
IPC: C07K16/28 , A61K39/00 , A61K39/395 , A61P35/00
CPC classification number: A61K39/0011
Abstract: The present invention relates to new uses of LTK in the diagnosis, screening, treatment and prophylaxis of ovarian and lung cancer. The invention also provides compositions comprising LTK, including vaccines, antibodies that are immunospecific for LTK and agents which interact with or modulate the expression or activity of LTK or which modulate the expression of the nucleic acid which codes for LTK.
Abstract translation: 本发明涉及LTK在诊断，筛选，治疗和预防卵巢癌和肺癌中的新用途。 本发明还提供包含LTK的组合物，包括疫苗，对LTK具有免疫特异性的抗体和与LTK的表达或活性相互作用或调节LTK的表达或活性或调节编码LTK的核酸表达的试剂。
-
公开(公告)号：WO2005023859A1
公开(公告)日：2005-03-17
申请号：PCT/GB2004/003643
申请日：2004-08-27
Applicant: CELLTECH R & D LIMITED , STAMPS, Alasdair Craig
Inventor： STAMPS, Alasdair Craig
IPC: C07K14/47
CPC classification number: G01N33/57423 , A61K38/1709 , C07K14/47 , G01N33/57438 , G01N2500/00 , G01N2800/52
Abstract: The present invention provides a polypeptide, KIAA0659, of use in the treatment and/or prophylaxis of carcinoma. Also provided are agents which interact with or modulate the expression or activity of the polypeptide, methods for the identification of such agents and the use of KIAA0659 in the diagnosis of carcinoma.
Abstract translation: 本发明提供了用于治疗和/或预防癌症的多肽KIAA0659。 还提供了与多肽的表达或活性相互作用或调节的试剂，用于鉴定此类试剂的方法以及KIAA0659在癌症诊断中的应用。
-
公开(公告)号：WO2003087831A3
公开(公告)日：2003-10-23
申请号：PCT/GB2003/001559
申请日：2003-04-10
Applicant: OXFORD GLYCOSCIENCES (UK) LTD , HUDSON, Lyndsey, J , STAMPS, Alasdair, Craig , TERRETT, Jonathan, Alexander
IPC: G01N33/574
Abstract: The present invention provides methods and compositions for the screening, diagnosis and therapy of breast cancer, for monitoring the effectiveness of breast cancer treatment, and for drug development.
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.023 seconds)
